http://www.unboundmedicine.com/medline/ebm/research/candesartanUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19927151/full_citation/Comparison_of_the_long_term_effects_of_candesartan_and_olmesartan_on_plasma_angiotensin_II_and_left_ventricular_mass_index_in_patients_with_hypertension_Tsutamoto T, Nishiyama K, Yamaji M, et al. 
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension. [JOURNAL ARTICLE]
Hypertens Res 2009 Nov 20.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19922631/full_citation/The_rationale_and_design_of_the_antihypertensives_and_vascular_endothelial_and_cognitive_function__AVEC__trial_in_elderly_hypertensives_with_early_cognitive_impairment:_Role_of_the_renin_angiotensin_system_inhibition_Hajjar I, Hart M, Milberg W, et al. 
The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition. [JOURNAL ARTICLE]
BMC Geriatr 2009 Nov 18; 9(1):48.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19914261/full_citation/Interaction_of_angiotensin_II_type_1_receptor_blockers_with_P_gp_substrates_in_Caco_2_cells_and_hMDR1_expressing_membranes_Kamiyama E, Nakai D, Mikkaichi T, et al. 
Interaction of angiotensin II type 1 receptor blockers with P-gp substrates in Caco-2 cells and hMDR1-expressing membranes. [JOURNAL ARTICLE]
Life Sci 2009 Nov 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19907343/full_citation/Renal_vasoconstrictor_and_pressor_responses_to_angiotensin_IV_in_mice_are_AT1a_receptor_mediated_Yang R, Walther T, Gembardt F, et al. 
Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated. [JOURNAL ARTICLE]
J Hypertens 2009 Nov 10.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19906946/full_citation/Stretch_Reduces_Nephrin_Expression_via_an_Angiotensin_II_AT1_dependent_Mechanism_in_Human_Podocytes:_Effect_of_Rosiglitazone_Miceli I, Burt D, Tarabra E, et al. 
Stretch Reduces Nephrin Expression via an Angiotensin II-AT1-dependent Mechanism in Human Podocytes: Effect of Rosiglitazone. [JOURNAL ARTICLE]
Am J Physiol Renal Physiol 2009 Nov 11.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19903833/full_citation/Prehypertensive_preconditioning_improves_adult_antihypertensive_and_cardioprotective_treatment_Baumann M, Sollinger D, Roos M, et al. 
Prehypertensive preconditioning improves adult antihypertensive and cardioprotective treatment. [JOURNAL ARTICLE]
J Pharmacol Exp Ther 2009 Nov 10.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19903661/full_citation/Feasibility_of_combined_treatment_with_enalapril_and_candesartan_in_advanced_chronic_kidney_disease_Frimodt-Møller M, Høj Nielsen A, Strandgaard S, et al. 
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease. [JOURNAL ARTICLE]
Nephrol Dial Transplant 2009 Nov 9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19890371/full_citation/Effects_of_losartan_vs_candesartan_in_reducing_cardiovascular_events_in_the_primary_treatment_of_hypertension_Kjeldsen SE, Stålhammar J, Hasvold P, et al. 
Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension. [JOURNAL ARTICLE]
J Hum Hypertens 2009 Nov 5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887503/full_citation/Candesartan_improves_blood_pressure_control_and_reduces_proteinuria_in_renal_transplant_recipients:_results_from_SECRET_Philipp T, Martinez F, Geiger H, et al. 
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. [JOURNAL ARTICLE]
Nephrol Dial Transplant 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886856/full_citation/Spironolactone_and_Chlorthalidone_in_Uncontrolled_Elderly_Hypertensive_Patients_Treated_with_Calcium_Antagonists_and_Angiotensin_II_Receptor_Blocker:_Effects_on_Endothelial_Function_Inflammation_and_Oxidative_Stress_Yamanari H, Nakamura K, Miura D, et al. 
Spironolactone and Chlorthalidone in Uncontrolled Elderly Hypertensive Patients Treated with Calcium Antagonists and Angiotensin II Receptor-Blocker: Effects on Endothelial Function, Inflammation, and Oxidative Stress. [Journal Article]
Clin Exp Hypertens 2009 Oct; 31(7):585-94.
Abstract | Full Citation | Find Related Articles